Zobrazeno 1 - 10
of 80
pro vyhledávání: '"S. Cayeux)"'
Publikováno v:
Le Pharmacien Clinicien. 57:e180-e181
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b01704159a5d6d6b81692c8fa173bc27
https://doi.org/10.1016/j.phacli.2022.10.699
https://doi.org/10.1016/j.phacli.2022.10.699
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 56:87-90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9ea729e3fd6f3a09e8d0126a39436f2
https://doi.org/10.1016/j.phclin.2020.08.005
https://doi.org/10.1016/j.phclin.2020.08.005
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 54:156-164
Resume Introduction Chez le sujet âge, la prise en charge de l’anxiete, des troubles du sommeil, des troubles dyspeptiques et de la constipation est presque systematiquement dependante de therapies medicamenteuses. Cela induit une iatrogenie impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4d80694c349a1ef044d8484014b5d50
https://doi.org/10.1016/j.phclin.2018.09.009
https://doi.org/10.1016/j.phclin.2018.09.009
Publikováno v:
Section 2: Selection, Procurement and Distribution.
Background To reduce counterfeit drugs, the serialisation will become mandatory on 9 February 2019. A DataMatrix code will be used to encode each secondary packaging. This 2D barcode makes it possible to indicate an important number of traceability d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4d03327870f80d632102b941d532303
https://doi.org/10.1136/ejhpharm-2019-eahpconf.61
https://doi.org/10.1136/ejhpharm-2019-eahpconf.61
Publikováno v:
Section 2: Selection, Procurement and Distribution.
Background The supply of health products is a major activity for hospital pharmacists. Its complexity is based on the need to hold sufficient stock at a reasonable cost while avoiding overstocking of products and therefore money. In our institution,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88baa037c1392e04b1a155aba2fe946e
https://doi.org/10.1136/ejhpharm-2019-eahpconf.60
https://doi.org/10.1136/ejhpharm-2019-eahpconf.60
Autor:
Antonio Pezzutto, S. Cayeux, Günther Richter, Bernd Dörken, Christian Becker, Thomas Blankenstein
Publikováno v:
European Journal of Immunology. 29:225-234
The mechanisms by which dendritic cell (DC) vaccines prime host T cells in vivo was analyzed. Mice were immunized with syngeneic bone marrow-derived DC and as surrogate antigen beta-galactosidase (beta-gal) was used. DC either pulsed with peptide, lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ab22e1533525e2ac82ac3a492b1acb0
https://doi.org/10.1002/(sici)1521-4141(199901)29:01<225::aid-immu225>3.0.co
https://doi.org/10.1002/(sici)1521-4141(199901)29:01<225::aid-immu225>3.0.co
Publikováno v:
The Journal of Immunology. 159:3808-3815
Expression of B7 on tumor cells can circumvent T cell tolerance and lead to the generation of tumor cell-specific T cell immunity. The effect of B7 expression on the generation of protective antitumor immunity has been attributed primarily to 1) more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa7a59a3d59745350da7ba3dd39dfd0f
https://doi.org/10.4049/jimmunol.159.8.3808
https://doi.org/10.4049/jimmunol.159.8.3808
Autor:
Thomas Blankenstein, S. Cayeux, Günther Richter, Antonio Pezzutto, Christian Becker, Alexandra Aicher, Bernd Dörken, Christian Beck
Publikováno v:
European Journal of Immunology. 27:1657-1662
Genetically modifying tumor cells to express a variety of cytokines such as interleukin-2 (IL-2) or the co-stimulatory molecule B7.1 leads to increased immunogenicity and reduced tumorigenicity of tumors in several models with T cells involved in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baa74b991ec68776587350bb2dae1ca9
https://doi.org/10.1002/eji.1830270710
https://doi.org/10.1002/eji.1830270710
Publikováno v:
The Journal of Immunology. 158:2834-2841
Tumor cells genetically modified to coexpress certain cytokines (such as IL-7 or IL-4) and B7.1 have increased immunogenicity. Since tumor Ags can be presented either directly by tumor cells or indirectly by host APC (cross-priming), we asked whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::068af1af5c44608ece8482c0e6ab5e73
https://doi.org/10.4049/jimmunol.158.6.2834
https://doi.org/10.4049/jimmunol.158.6.2834
Publikováno v:
European Journal of Immunology. 25:2325-2331
Interleukin-7 (IL-7) and the membrane molecule B7 are both able to provide proliferation and activation signals for T cells. However, tumor cells transfected to express either molecule alone are not reliably rejected in syngeneic hosts or are not suf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a679337a6d4c5125f8ec3e9d2c637a
https://doi.org/10.1002/eji.1830250831
https://doi.org/10.1002/eji.1830250831